Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Diagnostics company Quotient Ltd. raises $120mm through two closings of redeemable senior notes

Executive Summary

Quotient Ltd. (diagnostics for blood grouping and serological disease screening) grossed $120mm through a redeemable senior secured notes offering due 2023. The company has already raised a total of $54.2mm this year through two follow-on public offerings to fund its MosaiQ product.
Deal Industry
  • In Vitro Diagnostics
    • Hematology, Coagulation
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement
    • Other
    • Royalty Sale

Related Companies